The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 45
Summary
- Conditions
- Contraception
- Migraine
- Migraine;Menstrual
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: Prospective, non-inferiority study to evaluate the pharmacokinetic effect of topiramate on serum ENG levels in contraceptive implant usersMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 45 years
- Gender
- Only males
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03335163
- Collaborators
- Merck Sharp & Dohme Corp.
- Investigators
- Principal Investigator: Stephanie Teal, MD University of Colorado School of Medicine